Invest in These Biotech Stocks with Millionaire Potential
3 Millionaire-Maker Biotech Stocks
The risk at these companies is above average, and they're sure to remain volatile. This volatility, however, includes explosively bullish potential. It's been a tough past three years for biotech stocks. Although the COVID-19 pandemic sparked bullish interest in the industry, this interest has waned since the contagion began winding down. Between late 2021 and now, the Nasdaq Biotechnology Index is down on the order of 25% versus roughly a breakeven for the board market.
Iovance Biotherapeutics
Cancer treatments aren't exactly a new idea, but the approach Iovance Biotherapeutics (NASDAQ: IOVA) is taking to treat this highly varied disease is still relatively unique -- and promising.
- Iovance's core science is the development of tumor-infiltrating, or TILs.
- Enter Iovance Biotherapeutics.
- Although it's only FDA-approved to treat a very narrow sliver of metastatic melanoma patients, it's a start that can be expanded.
Recursion Pharmaceuticals
Recursion Pharmaceuticals (NASDAQ: RXRX) is categorized as a biotech company, but the label doesn't do it justice.
- This approach is certainly cheaper, easier, and faster than performing clinical trials based on nothing more than mere hope.
- Don't let that deter you too much, though.
Viking Therapeutics
Last but not least, add Viking Therapeutics (NASDAQ: VKTX) to your list of potential millionaire-maker biotech stocks.
- Viking'a specialty is rare metabolic and endocrine disorders.
- This might help make the bullish case.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.